Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » NantHealth Q2 Revenues Decline 12 Percent

NantHealth Q2 Revenues Decline 12 Percent

Aug 06, 2020
|
staff reporter

NEW YORK – NantHealth said Thursday after the close of the market that its second quarter revenues declined 12 percent to $17.6 million from $20.1 million in Q2 2019

The Culver City, California-based company had total software-related revenues of $17.5 million, down 4 percent from $18.3 million in Q2 2019. All software-related revenues now come from software-as-a-service (SaaS) offerings.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Letter Urges New Inquiry

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

Great Apes Get Shots, Too

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Woodcock on Vaccines, More

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

Science Paper Examines Molecular Contributors to Kidney Fibrosis

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.

What's Popular?

In Business News

  1. Spatial Omics Firms Use AGBT as Launchpad for New Tech

    Premium

  2. Illumina Receives Medical Device Registration in Russia for NextSeq 550 Dx Sequencer, Reagents

  3. New Products Posted to GenomeWeb: Purigen Biosystems, Zymo Research, Qiagen, More

  4. Agilent Charges Into Liquid Biopsy Space with Resolution Biosciences Acquisition

    Premium

  5. Bio-Techne to Acquire Molecular Diagnostics Firm Asuragen for up to $320M

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.